Kinnari Patel is COO at ROCKET PHARMACEUTICALS, INC. (RCKT). They have made 13 open-market trades across 1 company since 2018, most recently 2025-05-20.
CIK 0001725929
3 open-market purchases totalling $378K since 2018, against 10 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RCKT | 441,927 | $961K |
Shares reported on the most recent Form 4, priced at the 2025-05-22 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RCKT | SELL | 2025-05-20 | 2025-05-22 | $6.45 | $5K | -54.0% | -58.6% | -40.9% |
| RCKT | SELL | 2025-05-16 | 2025-05-20 | $6.53 | $9K | -58.5% | -59.6% | -54.6% |
| RCKT | BUY | 2025-04-09 | 2025-04-10 | $4.70 | $198K | +39.3% | +36.6% | -37.6% |
| RCKT | SELL | 2025-02-21 | 2025-02-25 | $10.58 | $129K | -7.8% | -17.1% | -75.5% |
| RCKT | SELL | 2024-11-21 | 2024-11-25 | $13.05 | $120K | -0.6% | -14.0% | -28.1% |
| RCKT | SELL | 2024-08-16 | 2024-08-20 | $18.50 | $148K | -3.0% | +9.9% | -29.7% |
| RCKT | SELL | 2024-05-16 | 2024-05-20 | $23.35 | $189K | -5.9% | -7.9% | -15.2% |
| RCKT | SELL | 2024-02-16 | 2024-02-21 | $29.84 | $426K | +1.0% | -4.3% | -21.5% |
| RCKT | SELL | 2023-08-17 | 2023-08-21 | $15.47 | $24K | -1.4% | +38.3% | +38.6% |
| RCKT | SELL | 2023-05-17 | 2023-05-19 | $21.38 | $28K | -4.7% | +2.9% | -30.2% |
| RCKT | SELL | 2020-12-28 | 2020-12-30 | $56.72 | $1.9M | -1.7% | -2.7% | -23.4% |
| RCKT | BUY | 2020-03-18 | 2020-03-19 | $9.50 | $10K | +2.6% | +28.7% | +50.4% |
| RCKT | BUY | 2018-12-06 | 2018-12-10 | $14.98 | $170K | -16.2% | +11.0% | +7.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.